Helicobacter pylori has been confirmed as a major cause of chronic gastritis, peptic ulcers, and even gastric cancer. The infection rate of Helicobacter pylori in China is very high, exceeding 50%. It is related to the dietary structure in China, often linked significantly to the practice of sharing dishes during meals, which correlates with China's dietary habits. If someone tests positive for Helicobacter pylori and has symptoms of gastrointestinal disorders, such as indigestion, stomach pain, or bloating, then it is necessary to undergo treatment for Helicobacter pylori. The current standard treatment for Helicobacter pylori involves quadruple therapy: a proton pump inhibitor, two types of antibiotics, and a bismuth agent. This combination of medications is administered over a period of 14 days, representing the standardized treatment for Helicobacter pylori.